The detection of EBP50 expression using quantum dot immunohistochemistry in pancreatic cancer tissue and down-regulated EBP50 effect on PC-2 cells

Journal of Molecular Histology

Volumn 43, Issue 5, 2012, Pages 517-526

  Ji, Meng Yao ^a   Fan, Di Kun ^b   Lv, Xiao Guang ^a   Peng, Xiu Lan ^a   Lei, Xiao Fei ^a   Dong, Wei Guo ^a  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b Center Hospital of Nanyang   (China)

Author keywords

Carcinogenesis; EBP50; Pancreatic cancer; Proliferation

Indexed keywords

BETA CATENIN; CYCLIN E; EZRIN RADIXIN MOESIN BINDING PHOSPHOPROTEIN 50; PROTEIN P27; QUANTUM DOT; RETINOBLASTOMA PROTEIN; SMALL INTERFERING RNA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANCHORAGE INDEPENDENT GROWTH; APICAL MEMBRANE; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; QUANTUM DOT IMMUNOHISTOCHEMISTRY; TUMOR GROWTH;

BETA CATENIN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN E; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; PANCREATIC NEOPLASMS; PHOSPHOPROTEINS; PROLIFERATING CELL NUCLEAR ANTIGEN; QUANTUM DOTS; RNA, SMALL INTERFERING; SODIUM-HYDROGEN ANTIPORTER;

EID: 84871270635     PISSN: 15672379     EISSN: 15672387     Source Type: Journal    
DOI: 10.1007/s10735-012-9424-0     Document Type: Article

References (36)

1. Bartholow TL, Becich MJ, Chandran UR, Parwani AV (2011) Immunohistochemical analysis of ezrin-radixin-moesin-binding phosphoprotein 50 in prostatic adenocarcinoma. BMC Urol 11:11-12
2. Chen H, Xue J, Zhang Y, Zhu X, Gao J, Yu B (2009) Comparison of quantum dots immnofluorescence histochemistry and conventional immunohistochemistry for the detection of caveolin-1 and PCNA in the lung cancer tissue microarray. J Mol Hist 40: 261-268
3. Chung C, Mader CC, Schmitz JC, Atladottir J, Fitchev P, Cornwell ML, Koleske AJ, Crawford SE, Gorelick F (2011) The vacuolar-ATPase modulates matrix metalloproteinase isoforms in human pancreatic cancer. Lab Invest 91:732-743
4. Clapéron A, Mergey MM, Fouassier L (2011) Roles of the scaffolding proteins NHERF in liver biology. Clin Res Hepatol Gastroenterol 35:176-1781
5. Curto M, Cole BK, Lallemand D, Liu CH, McClatchey AI (2007) Contact-dependent inhibition of EGFR signaling by Nf2/Merlin. J Cell Biol 177:893-903
6. Georgescu MM, Morales FC, Molina JR, Hayashi Y (2008) Roles of NHERF1/EBP50 in cancer. Curr Mol Med 8:459-468
7. Ghaneh P, Costello E, Neoptolemos JP (2008) Biology and management of pancreatic cancer. Postqrad Med J 84:478-497
8. Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, Lander ES (2009) Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 138:645-659
9. Hawes RH, Xiong Q, Waxman I, Chang KJ, Evans DB, Abbruzzese JL (2000) A multispecialty approach to the diagnosis and management of pancreatic cancer. Am J Gastroenterol 95:17-31
10. Hayashi Y, Molina JR, Hamilton SR, Georgescu MM (2010) NHERF1/EBP50 is a new marker in colorectal cancer. Neoplasia 12:1013-1022
11. Heiser PW, Cano DA, Landsman L, Kim GE, Kench JG, Klimstra DS, Taketo MM, Biankin AV, Hebrok M (2008) Stabilization of beta-catenin induces pancreas tumor formation. Gastroenterology 135:1288-1300
12. Hotz B, Arndt M, Dullat S, Bhargava S, Buhr HJ, Hotz HG (2007) Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer. Clin Cancer Res 13:4769-4776
13. James MF, Beauchamp RL, Manchanda N, Kazlauskas A, Ramesh V (2004) A NHERF binding site links the betaPDGFR to the cytoskeleton and regulates cell spreading and migration. J Cell Sci 117:2951-2961
14. Koleske AJ, Baltimore D, Lisanti MP (1995) Reduction of caveolin and caveolae in oncogenically transformed cells. Proc Natl Acad Sci USA 92:1381-1385
15. Kreimann EL, Morales FC, de Orbeta-Cruz J, Takahashi Y, Adams H, Liu TJ, McCrea PD, Georgescu MM (2007) Cortical stabilization of beta-catenin contributes to NHERF1/EBP50 tumor suppressor function. Oncogene 26:5290-5299
16. Lin PP, Pandey MK, Jin F, Raymond AK, Akiyama H, Lozano G (2009) Targeted mutation of p53 and Rb in mesenchymal cells of the limb bud produces sarcomas in mice. Carcinogenesis 30:1789-1795
17. Ling Y, Chen Y, Chen P, Hui H, Song X, Lu Z, Li C, Lu N, Guo Q (2011) Baicalein potently suppresses angiogenesis induced by vascular endothelial growth factor through the p53/Rb signaling pathway leading to G1/S cell cycle arrest. Exp Biol Med (Maywood) 236:851-858
18. Lowy AM, Knight J, Groden J (2002) Restoration of E-cadherin/betacatenin expression in pancreatic cancer cells inhibits growth by induction of apoptosis. Surgery 132:141-148
19. Mullin JM (2004) Epithelial barriers, compartmentation, and cancer. Sci STKE 2004:pe2
20. Murthy A, Gonzalez-Agosti C, Cordero E, Pinney D, Candia C, Solomon F, Gusella J, Ramesh V (1998) NHE-RF, a regulatory cofactor for Na(?)-H exchange, is a common interactor for merlin and ERM (MERM) proteins. J Biol Chem 273:1273-1276
21. Raimondi S, Maisonneuve P, Lowenfels AB (2009) Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol 6:699-708
22. Reczek D, Berryman M, Bretscher A (1997) Identification of EBP50: a PDZ-containing phosphoprotein that associates with members of the ezrin-radixin-moesin family. J Cell Biol 139:169-179
23. Sauter G, Simon R, Hillan K (2003) Tissue microarrays in drug discovery. Nat Rev Drug Discov 2:962-972
24. Schmalhofer O, Brabletz S, Brabletz T (2009) E-cadherin, betacatenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 28:151-166
25. Sommi P, Savio M, Stivala LA, Scotti C, Mignosi P, Prosperi E, Vannini V, Solcia E (2002) Helicobacter pylori releases a factor(s) inhibiting cell cycle progression of human gastric cell lines by affecting cyclin E/cdk2 kinase activity and Rb protein phosphorylation through enhanced p27(KIP1) protein expression. Exp Cell Res 281:128-139
26. Takahashi Y, Morales FC, Kreimann EL, Georgescu MM (2006) PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling. EMBO J 25:910-920
27. Tang S, Yang G, Meng Y, Du R, Li X, Fan R, Zhao L, Bi Q, Jin J, Gao L, Zhang L, Li H, Fan M, Wang Y, Wu K, Liu J, Fan D (2010) Overexpression of a novel gene gankyrin correlates with the malignant phenotype of colorectal cancer. Cancer Biol Ther 9:88-95
28. Thiery JP (2003) Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 15:740-746
29. Tholouli E, Sweeney E, Barrow E, Clay V, Hoyland JA, Byers RJ (2008) Quantum dots light up pathology. J Pathol 216:275-285
30. Toh B, Wang X, Keeble J, Sim WJ, Khoo K, Wong WC, Kato M, Prevost-Blondel A, Thiery JP, Abastado JP (2011) Mesenchymal transition and dissemination of cancer cells is driven by myeloidderived suppressor cells infiltrating the primary tumor. PLoS Biol 9:e1001162
31. Vorob'ev IA, Rafalovskaia-Orlovskaia EP, Gladkikh AA, Potashnkova DM, Barteneva NS (2011) Applications of fluorescent semiconductor nanocrystals in microscopy and cytometry. Tsitologiia 53:392-403
32. Weinman EJ, Steplock D, Wang Y, Shenolikar S (1995) Characterization of a protein cofactor that mediates protein kinase A regulation of the renal brush border membrane Na(?)-Hexchanger. J Clin Invest 95:2143-2149
33. Weinman EJ, Wang Y, Wang F, Greer C, Steplock D, Shenolikar S (2003) A C-terminal PDZ motif in NHE3 binds NHERF-1 and enhances cAMP inhibition of sodium-hydrogen exchange. Biochemistry 42:12662-12668
34. Wheeler DS, Barrick SR, Grubisha MJ (2011) Direct interaction between NHERF1 and Frizzled regulates b-catenin signaling. Oncogene 30:32-42
35. Yang XQ, Chen C, Peng CW, Hou JX, Liu SP, Qi CB, Gong YP, Zhu XB, Pang DW, Li Y (2011) Quantum dot-based quantitative immunofluorescence detection and spectrum analysis of epidermal growth factor receptor in breast cancer tissue arrays. Int J Nanomedicine 6:2265-2273
36. Zheng JF, Sun LC, Liu H, Huang Y, Li Y, He J (2010) EBP50 exerts tumor suppressor activity by promoting cell apoptosis and retarding extracellular signal-regulated kinase activity. Amino Acids 38:1261-1268